uracil has been researched along with Age-Related Memory Disorders in 3 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Semenov, VE | 4 |
| Zueva, IV | 4 |
| Lushchekina, SV | 4 |
| Suleimanov, EG | 3 |
| Gubaidullina, LM | 4 |
| Shulaeva, MM | 3 |
| Lenina, OA | 4 |
| Petrov, KA | 4 |
| Mukhamedyarov, MA | 1 |
| Petukhova, EO | 1 |
| Krylova, ES | 1 |
| Saifina, LF | 1 |
| Saad, MA | 1 |
| Rastanawi, AA | 1 |
| El-Yamany, MF | 1 |
3 other studies available for uracil and Age-Related Memory Disorders
| Article | Year |
|---|---|
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Ammonium Compounds; Animals; Anions; Behavior, Animal; Bind | 2020 |
Alogliptin abates memory injuries of hepatic encephalopathy induced by acute paracetamol intoxication via switching-off autophagy-related apoptosis.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Apoptosis; Autophagy; Be | 2018 |